Free access
Issue
Vet. Res.
Volume 35, Number 4, July-August 2004
Equine infectious diseases
Page(s) 485 - 512
DOI http://dx.doi.org/10.1051/vetres:2004020
How to cite this article Vet. Res. (2004) 485-512
References of Vet. Res. 35 485-512
  1. Albrecht T.R., Lund L.H., Garcia-Blanco M.A., Canine cyclin T1 rescues equine infectious anemia virus tat trans-activation in human cells, Virology 268 (2000) 7-11.
  2. Axthelm M.K., Krakowka S., Canine distemper virus-induced thrombocytopenia, Am. J. Vet. Res. 48 (1987) 1269-1275.
  3. Baccam P., Thompson R.J., Li Y., Sparks W.O., Belshan M., Dorman K.S., Wannemuehler Y., Oaks J.L., Cornette J.L., Carpenter S., Subpopulations of equine infectious anemia virus Rev coexist in vivo and differ in phenotype, J. Virol. 77 (2003) 12122-12131.
  4. Bakhanashvili M., Hizi A., Fidelity of DNA synthesis exhibited in vitro by the reverse transcriptase of the lentivirus equine infectious anemia virus, Biochemistry 32 (1993) 7559-7567.
  5. Ball J.M., Rushlow K.E., Issel C.J., Montelaro R.C., Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies, J. Virol. 66 (1992) 732-742.
  6. Belshan M., Harris M.E., Shoemaker A.E., Hope T.J., Carpenter S., Biological characterization of Rev variation in equine infectious anemia virus, J. Virol. 72 (1998) 4421-4426.
  7. Belshan M., Baccam P., Oaks J.L., Sponseller B.A., Murphy S.C., Cornette J., Carpenter S., Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony, Virology 279 (2001) 185-200.
  8. Benton C.V., Brown B.L., Harshman J.S., Gilden R.V., In vitro host range of equine infectious anemia virus, Intervirology 16 (1981) 225-232.
  9. Bieniasz P.D., Grdina T.A., Bogerd H.P., Cullen B.R., Highly divergent lentiviral Tat proteins activate viral gene expression by a common mechanism, Mol. Cell. Biol. 19 (1999) 4592-4599.
  10. Bouillant A.M., Nielsen K., Ruckerbauer G.M., Samagh B.S., Hare W.C., The persistent infection of a canine thymus cell line by equine infectious anaemia virus and preliminary data on the production of viral antigens, J. Virol. Methods 13 (1986) 309-321.
  11. Brigati C., Giacca M., Noonan D.M., Albini A., HIV Tat, its targets and the control of viral gene expression, FEMS Microbiol. Lett. 220 (2003) 57-65.
  12. Burki F., Rossmanith W., Rossmanith E., Equine lentivirus, comparative studies on four serological tests for the diagnosis of equine infectious anaemia, Vet. Microbiol. 33 (1992) 353-360.
  13. Carpenter S., Chesebro B., Change in host cell tropism associated with in vitro replication of equine infectious anemia virus, J. Virol. 63 (1989) 2492-2496.
  14. Carpenter S., Alexandersen S., Long M.J., Perryman S., Chesebro B., Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus, J. Virol. 65 (1991) 1605-1610.
  15. Carvalho M., Derse D., Mutational analysis of the equine infectious anemia virus Tat- responsive element, J. Virol. 65 (1991) 3468-3474.
  16. Carvalho M., Derse D., Physical and functional characterization of transcriptional control elements in the equine infectious anemia virus promoter, J. Virol. 67 (1993) 2064-2074.
  17. Carvalho M., Derse D., The PU.1/Spi-1 proto-oncogene is a transcriptional regulator of a lentivirus promoter, J. Virol. 67 (1993) 3885-3890.
  18. Charman H.P., Bladen S., Gilden R.V., Coggins L., Equine infectious anemia virus: evidence favoring classification as a retrovirus, J. Virol. 19 (1976) 1073-1079.
  19. Chen C., Montelaro R.C., Characterization of RNA elements that regulate gag-pol ribosomal frameshifting in equine infectious anemia virus, J. Virol. 77 (2003) 10280-10287.
  20. Chen C., Li F., Montelaro R.C., Functional roles of equine infectious anemia virus Gag p9 in viral budding and infection, J. Virol. 75 (2001) 9762-9770.
  21. Chung H., Derse D., Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA, J. Biol. Chem. 276 (2001) 18960-18967.
  22. Clabough D.L., Gebhard D., Flaherty M.T., Whetter L.E., Perry S.T., Coggins L., Fuller F.J., Immune-mediated thrombocytopenia in horses infected with equine infectious anemia virus, J. Virol. 65 (1991) 6242-6251.
  23. Clements J.E., Gabuzda D.H., Gdovin S.L., Cell type specific and viral regulation of visna virus gene expression, Virus Res. 16 (1990) 175-183.
  24. Coggins L., Norcross N.L., Immunodiffusion reaction in equine infectious anemia, Cornell Vet. 60 (1970) 330.
  25. Coggins L., Norcross N.L., Nusbaum S.R., Diagnosis of equine infectious anemia by immunodiffusion test, Am. J. Vet. Res. 33 (1972) 11-18.
  26. Cole K.S., Rowles J.L., Jagerski B.A., Murphey-Corb M., Unangst T., Clements J.E., Robinson J., Wyand M.S., Desrosiers R.C., Montelaro R.C., Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity, J. Virol. 71 (1997) 5069-5079.
  27. Cole K.S., Murphey-Corb M., Narayan O., Joag S.V., Shaw G.M., Montelaro R.C., Common themes of antibody maturation to simian immunodeficiency virus, simian-human immunodeficiency virus, and human immunodeficiency virus type 1 infections, J. Virol. 72 (1998) 7852-7859.
  28. Cook R.F., Leroux C., Cook S.J., Berger S.L., Lichtenstein D.L., Ghabrial N.N., Montelaro R.C., Issel C.J., Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus, J. Virol. 72 (1998) 1383-1393.
  29. Cook R.F., Cook S.J., Berger S.L., Leroux C., Ghabrial N.N., Gantz M., Bolin P.S., Mousel M.R., Montelaro R.C., Issel C.J., Enhancement of equine infectious anemia virus virulence by identification and removal of suboptimal nucleotides, Virology 313 (2003) 588-603.
  30. Cook S.J., Cook R.F., Montelaro R.C., Issel C.J., Differential responses of Equus caballus and Equus asinus to infection with two pathogenic strains of equine infectious anemia virus, Vet. Microbiol. 79 (2001) 93-109.
  31. Costa L.R., Santos I.K., Issel C.J., Montelaro R.C., Tumor necrosis factor-alpha production and disease severity after immunization with enriched major core protein (p26) and/or infection with equine infectious anemia virus, Vet. Immunol. Immunopathol. 57 (1997) 33-47.
  32. Craigo J.K., Leroux C., Howe L., Steckbeck J.D., Cook S.J., Issel C.J., Montelaro R.C., Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication, J. Gen. Virol. 83 (2002) 1353-1359.
  33. Crawford T.B., Wardrop K.J., Tornquist S.J., Reilich E., Meyers K.M., McGuire T.C., A primary production deficit in the thrombocytopenia of equine infectious anemia, J. Virol. 70 (1996) 7842-7850.
  34. Cupp E.W., Kemen M.J., The role of stable flies and mosquitoes in the transmission of equine infectious anemia virus, Proc. Annu. Meet. US Anim. Health Assoc. 84 (1980) 362-367.
  35. DeVico A.L., Issel C.J., Le Grice S.F., Payne S.L., Montelaro R.C., Sarngadharan M.G., High prevalence of serum antibodies to equine infectious anemia virus reverse transcriptase, AIDS Res. Hum. Retroviruses 9 (1993) 7-11.
  36. Dorn P.L., Derse D., Cis- and trans-acting regulation of gene expression of equine infectious anemia virus, J. Virol. 62 (1988) 3522-3526.
  37. dos Reis J.K., Melo L.M., Rezende M.R., Leite R.C., Use of an ELISA test in the eradication of an equine infectious anaemia focus, Trop. Anim. Health Prod. 26 (1994) 65-68.
  38. Dufour C., Corcione A., Svahn J., Haupt R., Poggi V., Beka'ssy A.N., Scime R., Pistorio A., Pistoia V., TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro, Blood 102 (2003) 2053-2059.
  39. Evans D.T., O'Connor D.H., Jing P., Dzuris J.L., Sidney J., da Silva J., Allen T.M., Horton H., Venham J.E., Rudersdorf R.A., Vogel T., Pauza C.D., Bontrop R.E., DeMars R., Sette A., Hughes A.L., Watkins D.I., Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef, Nat. Med. 5 (1999) 1270-1276.
  40. Foil L.D., Meek C.L., Adams W.V., Issel C.J., Mechanical transmission of equine infectious anemia virus by deer flies (Chrysops flavidus) and stable flies (Stomoxys calcitrans), Am. J. Vet. Res. 44 (1983) 155-156.
  41. Foil L.D., Adams W.V., McManus J.M., Issel C.J., Bloodmeal residues on mouthparts of Tabanus fuscicostatus (Diptera: Tabanidae) and the potential for mechanical transmission of pathogens, J. Med. Entomol. 24 (1987) 613-616.
  42. Freed E.O., HIV-1 gag proteins: diverse functions in the virus life cycle, Virology 251 (1998) 1-15.
  43. Freed E.O., Viral late domains, J. Virol. 76 (2002) 4679-4687.
  44. Fujimiya Y., Perryman L.E., Crawford T.B., Leukocyte cytotoxicity in a persistent virus infection: presence of direct cytotoxicity but absence of antibody-dependent cellular cytotoxicity in horses infected with equine infectious anemia virus, Infect. Immun. 24 (1979) 628-636.
  45. Geels M.J., Cornelissen M., Schuitemaker H., Anderson K., Kwa D., Maas J., Dekker J.T., Baan E., Zorgdrager F., van den Burg R., van Beelen M., Lukashov V.V., Fu T.M., Paxton W.A., van der Hoek L., Dubey S.A., Shiver J.W., Goudsmit J., Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual, J. Virol. 77 (2003) 12430-12440.
  46. Gendelman H.E., Narayan O., Molineaux S., Clements J.E., Ghotbi Z., Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow, Proc. Natl. Acad. Sci. USA 82 (1985) 7086-7090.
  47. Gendelman H.E., Narayan O., Kennedy-Stoskopf S., Kennedy P.G., Ghotbi Z., Clements J.E., Stanley J., Pezeshkpour G., Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages, J. Virol. 58 (1986) 67-74.
  48. Goldsweig H.G., Grossman R., William D., Thrombocytopenia in homosexual men, Am. J. Hematol. 21 (1986) 243-247.
  49. Gutekunst D.E., Becvar C.S., Responses in horses infected with equine infectious anemia virus adapted to tissue culture, Am. J. Vet. Res. 40 (1979) 974-977.
  50. Haase A.T., Pathogenesis of lentivirus infections, Nature 322 (1986) 130-136.
  51. Hammond S.A., Cook S.J., Lichtenstein D.L., Issel C.J., Montelaro R.C., Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process, J. Virol. 71 (1997) 3840-3852.
  52. Hammond S.A., Cook S.J., Falo L.D.J., Issel C.J., Montelaro R.C., A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus, Virology 254 (1999) 37-49.
  53. Hammond S.A., Raabe M.L., Issel C.J., Montelaro R.C., Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus, Virology 262 (1999) 416-430.
  54. Hammond S.A., Li F., McKeon B.M.S., Cook S.J., Issel C.J., Montelaro R.C., Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus, J. Virol. 74 (2000) 5968-5981.
  55. Harrold S.M., Cook S.J., Cook R.F., Rushlow K.E., Issel C.J., Montelaro R.C., Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids, J. Virol. 74 (2000) 3112-3121.
  56. Hatanaka H., Lourin O., Rao Z., Fry E., Kingsman A., Stuart D.I., Structure of equine infectious anemia virus matrix protein, J. Virol. 76 (2002) 1876-1883.
  57. Hawkins J.A., Adams W.V., Cook L., Wilson B.H., Roth E.E., Role of horse fly (Tabanus fuscicostatus Hine) and stable fly (Stomoxys calcitrans L.) in transmission of equine infectious anemia to ponies in Louisiana, Am. J. Vet. Res. 34 (1973) 1583-1586.
  58. Hines R., Maury W., DH82 cells: a macrophage cell line for the replication and study of equine infectious anemia virus, J. Virol. Methods 95 (2001) 47-56.
  59. Hoffman D.W., White S.W., NMR analysis of the trans-activation response (TAR) RNA element of equine infectious anemia virus, Nucleic Acids Res. 23 (1995) 4058-4065.
  60. Hoffman D.W., Colvin R.A., Garcia-Blanco M.A., White S.W., Structural features of the trans-activation response RNA element of equine infectious anemia virus, Biochemistry 32 (1993) 1096-1104.
  61. Howe L., Leroux C., Issel C.J., Montelaro R.C., Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype, J. Virol. 76 (2002) 10588-10597.
  62. Hussain K.A., Issel C.J., Rwambo P.M., Arnizaut A.B., Ball J.M., Schnorr K.L., Montelaro R.C., Identification of gag precursor of equine infectious anaemia virus with monoclonal antibodies to the major viral core protein, p26, J. Gen. Virol. 69 (1988) 1719-1724.
  63. Issel C.J., Coggins L., Equine infectious anemia: current knowledge, J. Am. Vet. Med. Assoc. 174 (1979) 727-733.
  64. Issel C.J., Foil L.D., Studies on equine infectious anemia virus transmission by insects, J. Am. Vet. Med. Assoc. 184 (1984) 293-297.
  65. Issel C.J., Adams W.V.J., Meek L., Ochoa R., Transmission of equine infectious anemia virus from horses without clinical signs of disease, J. Am. Vet. Med. Assoc. 180 (1982) 272-275.
  66. Issel C.J., Horohov D.W., Lea D.F., Adams W.V.J., Hagius S.D., McManus J.M., Allison A.C., Montelaro R.C., Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus, J. Virol. 66 (1992) 3398-3408.
  67. Karlas J.A., Siebelink K.H., Peer M.A., Huisman W., Cuisinier A.M., Rimmelzwaan G.F., Osterhaus A.D., Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection, J. Gen. Virol. 80 (1999) 761-765.
  68. Katzmann D.J., Odorizzi G., Emr S.D., Receptor downregulation and multivesicular-body sorting, Nat. Rev. Mol. Cell Biol. 3 (2002) 893-905.
  69. Kaur A., Alexander L., Staprans S.I., Denekamp L., Hale C.L., McClure H.M., Feinberg M.B., Desrosiers R.C., Johnson R.P., Emergence of cytotoxic T lymphocyte escape mutations in nonpathogenic simian immunodeficiency virus infection, Eur. J. Immunol. 31 (2001) 3207-3217.
  70. Kemeny L.J., Mott L.O., Pearson J.E., Titration of equine infectious anemia virus. Effect of dosage on incubation time and clinical signs, Cornell Vet. 61 (1971) 687-695.
  71. Kettelhut I.C., Goldberg A.L., Tumor necrosis factor can induce fever in rats without activating protein breakdown in muscle or lipolysis in adipose tissue, J. Clin. Invest. 81 (1988) 1384-1389.
  72. Klevjer-Anderson P., Cheevers W.P., Crawford T.B., Characterization of the infection of equine fibroblasts by equine infectious anemia virus, Arch. Virol. 60 (1979) 279-289.
  73. Knowles D. Jr., Cheevers W., McGuire T., Stem T., Gorham J., Severity of arthritis is predicted by antibody response to gp135 in chronic infection with caprine arthritis-encephalitis virus, J. Virol. 64 (1990) 2396-2398.
  74. Kobayashi K., Kono Y., Propagation and titration of equine infectious anemia virus in horse leukocyte culture, Natl. Inst. Anim. Health Q. (Tokyo) 7 (1967) 8-20.
  75. Kono Y., Viremia and immunological responses in horses infected with equine infectious anemia virus, Natl. Inst. Anim. Health Q. (Tokyo) 9 (1969) 1-9.
  76. Kono Y., Kobayashi K., Changes in pathogenicity of equine infectious anemia virus during passages in horse leukocyte cultures, Natl. Inst. Anim. Health Q. (Tokyo) 10 (1970) 106-112.
  77. Kono Y., Yoshino T., Propagation of equine infectious anemia virus in horse kidney cell cultures, Natl. Inst. Anim. Health Q. (Tokyo) 14 (1974) 155-162.
  78. Kono Y., Kobayashi K., Fukunaga Y., Antigenic drift of equine infectious anemia virus in chronically infected horses, Arch. Gesamte Virusforsch. 41 (1973) 1-10.
  79. Kono Y., Hirasawa K., Fukunaga Y., Taniguchi T., Recrudescence of equine infectious anemia by treatment with immunosuppressive drugs, Natl. Inst. Anim. Health Q. (Tokyo) 16 (1976) 8-15.
  80. Koup R.A., Safrit J.T., Cao Y., Andrews C.A., McLeod G., Borkowsky W., Farthing C., Ho D.D., Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome, J. Virol. 68 (1994) 4650-4655.
  81. Leroux C., Issel C.J., Montelaro R.C., Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony, J. Virol. 71 (1997) 9627-9639.
  82. Leroux C., Chastang J., Greenland T., Mornex J.F., Genomic heterogeneity of small ruminant lentiviruses: existence of heterogeneous populations in sheep and of the same lentiviral genotypes in sheep and goats, Arch. Virol. 142 (1997) 1125-1137.
  83. Leroux C., Craigo J.K., Issel C.J., Montelaro R.C., Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies, J. Virol. 75 (2001) 4570-4583.
  84. Lew A.M., Thomas L.M., Huntington P.J., A comparison of ELISA, FAST-ELISA and gel diffusion tests for detecting antibody to equine infectious anaemia virus, Vet. Microbiol. 34 (1993) 1-5.
  85. Li F., Puffer B.A., Montelaro R.C., The S2 gene of equine infectious anemia virus is dispensable for viral replication in vitro, J. Virol. 72 (1998) 8344-8348.
  86. Li F., Leroux C., Craigo J.K., Cook S.J., Issel C.J., Montelaro R.C., The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies, J. Virol. 74 (2000) 573-579.
  87. Li F., Craigo J.K., Howe L., Steckbeck J.D., Cook S., Issel C., Montelaro R.C., A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses, J. Virol. 77 (2003) 7244-7253.
  88. Liang C., Wainberg M.A., The role of Tat in HIV-1 replication: an activator and/or a suppressor? AIDS Rev. 4 (2002) 41-49.
  89. Lichtenstein D.L., Rushlow K.E., Cook R.F., Raabe M.L., Swardson C.J., Kociba G.J., Issel C.J., Montelaro R.C., Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity, J. Virol. 69 (1995) 2881-2888.
  90. Lichtenstein D.L., Issel C.J., Montelaro R.C., Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus, J. Virol. 70 (1996) 3346-3354.
  91. Lichtenstein D.L., Craigo J.K., Leroux C., Rushlow K.E., Cook R.F., Cook S.J., Issel C.J., Montelaro R.C., Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo, Virology 263 (1999) 408-417.
  92. Ligné M., Mémoire et observations sur une maladie de sang, connue sous le nom d'anhémie hydrohémie, cachexie acquise du cheval, Rec. Med. Vet. Ec. Alfort 1843 (1843) 30-44.
  93. Lloberas J., Soler C., Celada A., The key role of PU.1/SPI-1 in B cells, myeloid cells and macrophages, Immunol. Today 20 (1999) 184-189.
  94. Lonning S.M., Zhang W., Leib S.R., McGuire T.C., Detection and induction of equine infectious anemia virus-specific cytotoxic T-lymphocyte responses by use of recombinant retroviral vectors, J. Virol. 73 (1999) 2762-2769.
  95. Lonning S.M., Zhang W., McGuire T.C., Gag protein epitopes recognized by CD4(+) T-helper lymphocytes from equine infectious anemia virus-infected carrier horses, J. Virol. 73 (1999) 4257-4265.
  96. Louache F., Bettaieb A., Henri A., Oksenhendler E., Farcet J.P., Bierling P., Seligmann M., Vainchenker W., Infection of megakaryocytes by human immunodeficiency virus in seropositive patients with immune thrombocytopenic purpura, Blood 78 (1991) 1697-1705.
  97. Louache F., Henri A., Bettaieb A., Oksenhendler E., Raguin G., Tulliez M., Vainchenker W., Role of human immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors, Blood 80 (1992) 2991-2999.
  98. Madden C.R., Shih D.S., Analysis of the long terminal repeat from a cytopathic strain of equine infectious anemia virus, Virology 225 (1996) 395-399.
  99. Malmquist W.A., Barnett D., Becvar C.S., Production of equine infectious anemia antigen in a persistently infected cell line, Arch. Gesamte Virusforsch. 42 (1973) 361-370.
  100. Martarano L., Stephens R., Rice N., Derse D., Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing, J. Virol. 68 (1994) 3102-3111.
  101. Martin-Serrano J., Yaravoy A., Perez-Caballero D., Bieniasz P.D., Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins, Proc. Natl. Acad. Sci. USA 100 (2003) 12414-12419.
  102. Maury W., Monocyte maturation controls expression of equine infectious anemia virus, J. Virol. 68 (1994) 6270-6279.
  103. Maury W., Perryman S., Oaks J.L., Seid B.K., Crawford T., McGuire T., Carpenter S., Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus, J. Virol. 71 (1997) 4929-4937.
  104. Maury W., Oaks J.L., Bradley S., Equine endothelial cells support productive infection of equine infectious anemia virus, J. Virol. 72 (1998) 9291-9297.
  105. Maury W., Bradley S., Wright B., Hines R., Cell specificity of the transcription-factor repertoire used by a lentivirus: motifs important for expression of equine infectious anemia virus in nonmonocytic cells, Virology 267 (2000) 267-278.
  106. Maury W., Wright P.J., Bradley S., Characterization of a cytolytic strain of equine infectious anemia virus, J. Virol. 77 (2003) 2385-2399.
  107. McGuire T.C., Crawford T.B., Henson J.B., Immunofluorescent localization of equine infectious anemia virus in tissue, Am. J. Pathol. 62 (1971) 283-294.
  108. McGuire T.C., Banks K.L., Poppie M.J., Combined immunodeficiency in horses: characterization of the lymphocyte defect, Clin. Immunol. Immunopathol. 3 (1975) 555-566.
  109. McGuire T.C., Adams D.S., Johnson G.C., Klevjer-Anderson P., Barbee D.D., Gorham J.R., Acute arthritis in caprine arthritis-encephalitis virus challenge exposure of vaccinated or persistently infected goats, Am. J. Vet. Res. 47 (1986) 537-540.
  110. McGuire T.C., Tumas D.B., Byrne K.M., Hines M.T., Leib S.R., Brassfield A.L., O'Rourke K.I., Perryman L.E., Major histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins, J. Virol. 68 (1994) 1459-1467.
  111. McGuire T.C., Zhang W., Hines M.T., Henney P.J., Byrne K.M., Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses, Virology 238 (1997) 85-93.
  112. McGuire T.C., Fraser D.G., Mealey R.H., Cytotoxic T lymphocytes and neutralizing antibody in the control of equine infectious anemia virus, Viral Immunol. 15 (2002) 521-531.
  113. Mealey R.H., Fraser D.G., Oaks J.L., Cantor G.H., McGuire T.C., Immune reconstitution prevents continuous equine infectious anemia virus replication in an arabian foal with severe combined immunodeficiency: lessons for control of lentiviruses, Clin. Immunol. 101 (2001) 237-247.
  114. Mealey R.H., Zhang B., Leib S.R., Littke M.H., McGuire T.C., Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus, Virology 313 (2003) 537-552.
  115. Mellors J.W., Rinaldo C.R. Jr., Gupta P., White R.M., Todd J.A., Kingsley L.A., Prognosis in HIV-1 infection predicted by the quantity of virus in plasma, Science 272 (1996) 1167-1170.
  116. Moldawer L.L., Marano M.A., Wei H., Fong Y., Silen M.L., Kuo G., Manogue K.R., Vlassara H., Cohen H., Cerami A., et al., Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo, Faseb J. 3 (1989) 1637-1643.
  117. Montelaro R.C., Parekh B., Orrego A., Issel C.J., Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus, J. Biol. Chem. 259 (1984) 10539-10544.
  118. Montelaro R.C., Cole K.S., Hammond S.A., Maturation of immune responses to lentivirus infection: implications for AIDS vaccine development, AIDS Res. Hum. Retroviruses 14 Suppl. 3 (1998) S255-259.
  119. Moore C.B., John M., James I.R., Christiansen F.T., Witt C.S., Mallal S.A., Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level, Science 296 (2002) 1439-1443.
  120. Narayan O., Kennedy-Stoskopf S., Sheffer D., Griffin D.E., Clements J.E., Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages, Infect. Immun. 41 (1983) 67-73.
  121. Nishimura Y., Igarashi T., Haigwood N., Sadjadpour R., Plishka R.J., Buckler-White A., Shibata R., Martin M.A., Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies, J. Virol. 76 (2002) 2123-2130.
  122. Noiman S., Yaniv A., Sherman L., Tronick S.R., Gazit A., Pattern of transcription of the genome of equine infectious anemia virus, J. Virol. 64 (1990) 1839-1843.
  123. O'Rourke K., Perryman L.E., McGuire T.C., Antiviral, anti-glycoprotein and neutralizing antibodies in foals with equine infectious anaemia virus, J. Gen. Virol. 69 (1988) 667-674.
  124. Oaks J.L., McGuire T.C., Ulibarri C., Crawford T.B., Equine infectious anemia virus is found in tissue macrophages during subclinical infection, J. Virol. 72 (1998) 7263-7269.
  125. Oaks J.L., Ulibarri C., Crawford T.B., Endothelial cell infection in vivo by equine infectious anaemia virus, J. Gen. Virol. 80 (1999) 2393-2397.
  126. Orrego A., Issel C.J., Montelaro R.C., Adams W.V.J., Virulence and in vitro growth of a cell-adapted strain of equine infectious anemia virus after serial passage in ponies, Am. J. Vet. Res. 43 (1982) 1556-1560.
  127. Parent L.J., Bennett R.P., Craven R.C., Nelle T.D., Krishna N.K., Bowzard J.B., Wilson C.B., Puffer B.A., Montelaro R.C., Wills J.W., Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins, J. Virol. 69 (1995) 5455-5460.
  128. Payne S.L., Rausch J., Rushlow K., Montelaro R.C., Issel C., Flaherty M., Perry S., Sellon D., Fuller F., Characterization of infectious molecular clones of equine infectious anaemia virus, J. Gen. Virol. 75 (1994) 425-429.
  129. Payne S.L., Qi X.M., Shao H., Dwyer A., Fuller F.J., Disease induction by virus derived from molecular clones of equine infectious anemia virus, J. Virol. 72 (1998) 483-487.
  130. Pearson J.E., Gipson C.A., Standardization of equine infectious anemia immunodiffusion and cELISA tests and their application to control of the disease in the United States, Equine Vet. Science 8 (1988) 60-61.
  131. Pedersen N.C., Johnson L., Birch D., Theilen G.H., Possible immunoenhancement of persistent viremia by feline leukemia virus envelope glycoprotein vaccines in challenge-exposure situations where whole inactivated virus vaccines were protective, Vet. Immunol. Immunopathol. 11 (1986) 123-148.
  132. Peluso R., Haase A., Stowring L., Edwards M., Ventura P., A Trojan Horse mechanism for the spread of visna virus in monocytes, Virology 147 (1985) 231-236.
  133. Perryman L.E., O'Rourke K.I., McGuire T.C., Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection, J. Virol. 62 (1988) 3073-3076.
  134. Preston B.D., Poiesz B.J., Loeb L.A., Fidelity of HIV-1 reverse transcriptase, Science 242 (1988) 1168-1171.
  135. Puffer B.A., Parent L.J., Wills J.W., Montelaro R.C., Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein, J. Virol. 71 (1997) 6541-6546.
  136. Puffer B.A., Watkins S.C., Montelaro R.C., Equine infectious anemia virus Gag polyprotein late domain specifically recruits cellular AP-2 adapter protein complexes during virion assembly, J. Virol. 72 (1998) 10218-10221.
  137. Raabe M.R., Issel C.J., Montelaro R.C., Equine monocyte-derived macrophage cultures and their applications for infectivity and neutralization studies of equine infectious anemia virus, J. Virol. Methods 71 (1998) 87-104.
  138. Raabe M.L., Issel C.J., Cook S.J., Cook R.F., Woodson B., Montelaro R.C., Immunization with a recombinant envelope protein (rgp90) of EIAV produces a spectrum of vaccine efficacy ranging from lack of clinical disease to severe enhancement, Virology 245 (1998) 151-162.
  139. Raabe M.L., Issel C.J., Montelaro R.C., In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus, Virology 259 (1999) 416-427.
  140. Rasty S., Dhruva B.R., Schiltz R.L., Shih D.S., Issel C.J., Montelaro R.C., Proviral DNA integration and transcriptional patterns of equine infectious anemia virus during persistent and cytopathic infections, J. Virol. 64 (1990) 86-95.
  141. Reed-Inderbitzin E., Maury W., Cellular specificity of HIV-1 replication can be controlled by LTR sequences, Virology 314 (2003) 680-695.
  142. Reis J.K., Craigo J.K., Cook S.J., Issel C.J., Montelaro R.C., Characterization of EIAV LTR variability and compartmentalization in various reservoir tissues of long-term inapparent carrier ponies, Virology 311 (2003) 169-180.
  143. Rice N.R., Lequarre A.S., Casey J.W., Lahn S., Stephens R.M., Edwards J., Viral DNA in horses infected with equine infectious anemia virus, J. Virol. 63 (1989) 5194-5200.
  144. Richardson J., Broche S., Baud S., Leste-Lasserre T., Femenia F., Levy D., Moraillon A., Pancino G., Sonigo P., Lymphoid activation: a confounding factor in AIDS vaccine development? J. Gen. Virol. 83 (2002) 2515-2521.
  145. Ridgely S.L., McGuire T.C., Lipopeptide stimulation of MHC class I-restricted memory cytotoxic T lymphocytes from equine infectious anemia virus-infected horses, Vaccine 20 (2002) 1809-1819.
  146. Ridgely S.L., Zhang B., McGuire T.C., Response of ELA-A1 horses immunized with lipopeptide containing an equine infectious anemia virus ELA-A1-restricted CTL epitope to virus challenge, Vaccine 21 (2003) 491-506.
  147. Roberts J.D., Bebenek K., Kunkel T.A., The accuracy of reverse transcriptase from HIV-1, Science 242 (1988) 1171-1173.
  148. Robertson D.L., Hahn B.H., Sharp P.M., Recombination in AIDS viruses, J. Mol. Evol. 40 (1995) 249-259.
  149. Rous P., A sarcoma of the fowl transmissible by an agent separable from the tumor cells, J. Exp. Med. 13 (1911) 397-411.
  150. Rwambo P.M., Issel C.J., Adams W.V. Jr., Hussain K.A., Miller M., Montelaro R.C., Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection, Arch. Virol. 111 (1990) 199-212.
  151. Salguero F.J., Ruiz-Villamor E., Bautista M.J., Sanchez-Cordon P.J., Carrasco L., Gomez-Villamandos J.C., Changes in macrophages in spleen and lymph nodes during acute African swine fever: expression of cytokines, Vet. Immunol. Immunopathol. 90 (2002) 11-22.
  152. Salinovich O., Payne S.L., Montelaro R.C., Hussain K.A., Issel C.J., Schnorr K.L., Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection, J. Virol. 57 (1986) 71-80.
  153. Schiltz R.L., Shih D.S., Rasty S., Montelaro R.C., Rushlow K.E., Equine infectious anemia virus gene expression: characterization of the RNA splicing pattern and the protein products encoded by open reading frames S1 and S2, J. Virol. 66 (1992) 3455-3465.
  154. Sellon D.C., Perry S.T., Coggins L., Fuller F.J., Wild-type equine infectious anemia virus replicates in vivo predominantly in tissue macrophages, not in peripheral blood monocytes, J. Virol. 66 (1992) 5906-5913.
  155. Sellon D.C., Fuller F.J., McGuire T.C., The immunopathogenesis of equine infectious anemia virus, Virus Res. 32 (1994) 111-138.
  156. Sentsui H., Kono Y., Complement-mediated hemolysis of horse erythrocytes treated with equine infectious anemia virus, Arch. Virol. 95 (1987) 53-66.
  157. Shen R., Wang Z.M., Development and use of an equine infectious aneamia donkey leukocyte attenuated vaccine, in: Tashjian R. (Ed.), Equine Infectious Anemia: a national review of policies, programs, and future objectives, Amarillo, Texas, 1985, pp. 135-148.
  158. Sherman L., Gazit A., Yaniv A., Kawakami T., Dahlberg J.E., Tronick S.R., Localization of sequences responsible for trans-activation of the equine infectious anemia virus long terminal repeat, J. Virol. 62 (1988) 120-126.
  159. Shibata R., Igarashi T., Haigwood N., Buckler-White A., Ogert R., Ross W., Willey R., Cho M.W., Martin M.A., Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys, Nat. Med. 5 (1999) 204-210.
  160. Soutullo A., Verwimp V., Riveros M., Pauli R., Tonarelli G., Design and validation of an ELISA for equine infectious anemia (EIA) diagnosis using synthetic peptides, Vet. Microbiol. 79 (2001) 111-121.
  161. Spyrou V., Papanastassopoulou M., Psychas V., Billinis C., Koumbati M., Vlemmas J., Koptopoulos G., Equine infectious anemia in mules: virus isolation and pathogenicity studies, Vet. Microbiol. 95 (2003) 49-59.
  162. Steagall W.K., Robek M.D., Perry S.T., Fuller F.J., Payne S.L., Incorporation of uracil into viral DNA correlates with reduced replication of EIAV in macrophages, Virology 210 (1995) 302-313.
  163. Stephens R.M., Casey J.W., Rice N.R., Equine infectious anemia virus gag and pol genes: relatedness to visna and AIDS virus, Science 231 (1986) 589-594.
  164. Stephens R.M., Derse D., Rice N.R., Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative Rev proteins, J. Virol. 64 (1990) 3716-3725.
  165. Sticht H., Willbold D., Bayer P., Ejchart A., Herrmann F., Rosin-Arbesfeld R., Gazit A., Yaniv A., Frank R., Rosch P., Equine infectious anemia virus Tat is a predominantly helical protein, Eur. J. Biochem. 218 (1993) 973-976.
  166. Strack B., Calistri A., Craig S., Popova E., Gottlinger H.G., AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding, Cell 114 (2003) 689-699.
  167. Sune C., Goldstrohm A.C., Peng J., Price D.H., Garcia-Blanco M.A., An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation, Virology 274 (2000) 356-366.
  168. Swanstrom R., Wills J.W., Synthesis, assembly, and processing of viral proteins, in: Coffin J.M., Hughes S.H., Varmus H.E. (Eds.), Retroviruses, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1997, pp. 263-334.
  169. Takada A., Kawaoka Y., Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications, Rev. Med. Virol. 13 (2003) 387-398.
  170. Tanzi G.O., Piefer A.J., Bates P., Equine infectious anemia virus utilizes host vesicular protein sorting machinery during particle release, J. Virol. 77 (2003) 8440-8447.
  171. Ten Haaft P., Verstrepen B., Uberla K., Rosenwirth B., Heeney J., A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques, J. Virol. 72 (1998) 10281-10285.
  172. Tencza S.B., Islam K.R., Kalia V., Nasir M.S., Jolley M.E., Montelaro R.C., Development of a fluorescence polarization-based diagnostic assay for equine infectious anemia virus, J. Clin. Microbiol. 38 (2000) 1854-1859.
  173. Thomas D.A., Furman P.A., Purification and kinetic characterization of equine infectious anemia virus reverse transcriptase, Biochem. Biophys. Res. Commun. 180 (1991) 1365-1371.
  174. Threadgill D.S., Steagall W.K., Flaherty M.T., Fuller F.J., Perry S.T., Rushlow K.E., Le Grice S.F., Payne S.L., Characterization of equine infectious anemia virus dUTPase: growth properties of a dUTPase-deficient mutant, J. Virol. 67 (1993) 2592-2600.
  175. Tornquist S.J., Oaks J.L., Crawford T.B., Elevation of cytokines associated with the thrombocytopenia of equine infectious anaemia, J. Gen. Virol. 78 (1997) 2541-2548.
  176. Tschetter J.R., Byrne K.M., Perryman L.E., McGuire T.C., Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies, Virology 230 (1997) 275-280.
  177. Tumas D.B., Hines M.T., Perryman L.E., Davis W.C., McGuire T.C., Corticosteroid immunosuppression and monoclonal antibody-mediated CD5+ T lymphocyte depletion in normal and equine infectious anaemia virus-carrier horses, J. Gen. Virol. 75 (1994) 959-968.
  178. Vallée H., Carré H., Sur la nature infectieuse de l'anémie du cheval, C. R. Acad. Sci. 139 (1904) 331-333.
  179. Van Regenmortel M.H., Mayo M.A., Fauquet C.M., Maniloff J., Virus nomenclature: consensus versus chaos, Arch. Virol. 145 (2000) 2227-2232.
  180. Villet S., Bouzar B.A., Morin T., Verdier G., Legras C., Chebloune Y., Maedi-visna virus and caprine arthritis encephalitis virus genomes encode a Vpr-like but no Tat protein, J. Virol. 77 (2003) 9632-9638.
  181. Villet S., Faure C., Bouzar B.A., Morin T., Verdier G., Chebloune Y., Legras C., Lack of trans-activation function for Maedi-visna virus and Caprine arthritis encephalitis virus Tat proteins, Virology 307 (2003) 317-327.
  182. Von Schwedler U.K., Stuchell M., Muller B., Ward D.M., Chung H.Y., Morita E., Wang H.E., Davis T., He G.P., Cimbora D.M., Scott A., Krausslich H.G., Kaplan J., Morham S.G., Sundquist W.I., The protein network of HIV budding, Cell 114 (2003) 701-713.
  183. Wang S.Z., Rushlow K.E., Issel C.J., Cook R.F., Cook S.J., Raabe M.L., Chong Y.H., Costa L., Montelaro R.C., Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein, Virology 199 (1994) 247-251.
  184. Whetter L., Archambault D., Perry S., Gazit A., Coggins L., Yaniv A., Clabough D., Dahlberg J., Fuller F., Tronick S., Equine infectious anemia virus derived from a molecular clone persistently infects horses, J. Virol. 64 (1990) 5750-5756.
  185. Willbold D., Rosin-Arbesfeld R., Sticht H., Frank R., Rosch P., Structure of the equine infectious anemia virus Tat protein, Science 264 (1994) 1584-1587.
  186. Yoon S., Kingsman S.M., Kingsman A.J., Wilson S.A., Mitrophanous K.A., Characterization of the equine infectious anaemia virus S2 protein, J. Gen. Virol. 81 (2000) 2189-2194.
  187. Zauli G., Re M.C., Davis B., Sen L., Visani G., Gugliotta L., Furlini G., La Placa M., Impaired in vitro growth of purified (CD34+) hematopoietic progenitors in human immuno-deficiency virus-1 seropositive thrombocytopenic individuals, Blood 79 (1992) 2680-2687.
  188. Zhang W., Lonning S.M., McGuire T.C., Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection, J. Virol. 72 (1998) 9612-9620.
  189. Zhang W., Auyong D.B., Oaks J.L., McGuire T.C., Natural variation of equine infectious anemia virus Gag protein cytotoxic T lymphocyte epitopes, Virology 261 (1999) 242-252.
  190. Zheng Y.H., Nakaya T., Sentsui H., Kameoka M., Kishi M., Hagiwara K., Takahashi H., Kono Y., Ikuta K., Insertions, duplications and substitutions in restricted gp90 regions of equine infectious anaemia virus during febrile episodes in an experimentally infected horse, J. Gen. Virol. 78 (1997) 807-820.
  191. Zheng Y.H., Sentsui H., Kono Y., Ikuta K., Mutations occurring during serial passage of Japanese equine infectious anemia virus in primary horse macrophages, Virus Res. 68 (2000) 93-98.
  192. Zientara S., L'anémie infectieuse des équidés: déjà 3 foyers en 1999, Bull. G.T.V. 1 (1999) 39-40.
  193. Zientara S., L'anémie infectieuse des équidés: la situation épidémiologique en France depuis 1993, Bull. G.T.V. 1 (1999) 41-43.
  194. Zucker-Franklin D., Cao Y.Z., Megakaryocytes of human immunodeficiency virus-infected individuals express viral RNA, Proc. Natl. Acad. Sci. USA 86 (1989) 5595-5599.
  195. Zucker-Franklin D., Seremetis S., Zheng Z.Y., Internalization of human immunodeficiency virus type I and other retroviruses by megakaryocytes and platelets, Blood 75 (1990) 1920-1923.